Hikma Pharmaceuticals Plc Company Profile (LON:HIK)

About Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc logoHikma Pharmaceuticals Plc is a pharmaceutical company. The Company develops, manufactures and markets a range of branded and non-branded generic pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms, across the United States, the Middle East and North Africa (MENA) region and Europe. The Company's segments include Branded, Injectables, Generics and Others. The Branded business sells branded generics and in-licensed products across the MENA region and other markets. The Injectables business sells specialized generic injectable products across the globe. The Generics business sells non-injectable generic products in the United States. The Branded business has approximately 380 products in over 1,120 dosage forms and strengths. Its products include Amoclan, Blopress, Omnicef, Prograf and Suprax. The Injectables business' products include Argatroban, Fentanyl, Glycopyrrolate, Nicardipine and Phenylephrine.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: HIK
  • CUSIP:
Key Metrics:
  • Previous Close: $25.35
  • 50 Day Moving Average: $1909.1600
  • 200 Day Moving Average: $1956.7400
  • 52-Week Range: £2,260,000 - GBX 1,575
  • Trailing P/E Ratio: 24.7980
  • P/E Growth: 1.1700
  • Market Cap: $4.58B
  • Outstanding Shares: 226,000,000
Additional Links:

Analyst Ratings

Consensus Ratings for Hikma Pharmaceuticals Plc (LON:HIK) (?)
Ratings Breakdown: 2 Hold Ratings, 9 Buy Ratings
Consensus Rating:Buy (Score: 2.82)
Consensus Price Target: GBX 2,300.30

Analysts' Ratings History for Hikma Pharmaceuticals Plc (LON:HIK)
DateFirmActionRatingPrice TargetDetails
1/25/2017Peel HuntInitiated CoverageBuyGBX 2,340View Rating Details
1/17/2017Jefferies Group LLCBoost Price TargetBuyGBX 2,065 -> GBX 2,162View Rating Details
1/17/2017J P Morgan Chase & CoReiterated RatingOverweightGBX 2,100View Rating Details
11/30/2016AlphaValueReiterated RatingBuyGBX 2,431View Rating Details
11/16/2016Citigroup Inc.Reiterated RatingNeutralView Rating Details
11/15/2016Morgan StanleyUpgradeEqual Weight -> OverweightGBX 2,500 -> GBX 2,200View Rating Details
11/11/2016HSBC Holdings plcLower Price TargetHoldGBX 1,985 -> GBX 1,800View Rating Details
11/10/2016Numis Securities LtdReiterated RatingBuyGBX 2,350View Rating Details
9/9/2016Barclays PLCReiterated RatingOverweightGBX 2,900View Rating Details
6/24/2016Stifel NicolausReiterated RatingBuyView Rating Details
3/16/2016Panmure GordonUpgradeBuyGBX 2,120View Rating Details
9/15/2015Goldman Sachs Group, Inc. (The)Reiterated RatingBuyView Rating Details
9/2/2015Shore CapitalUpgradeBuyView Rating Details
4/27/2015Beaufort SecuritiesReiterated RatingBuyView Rating Details
(Data available from 2/19/2015 forward)


Earnings History for Hikma Pharmaceuticals Plc (LON:HIK)
No earnings announcements for this company have been tracked by MarketBeat.com


Earnings Estimates for Hikma Pharmaceuticals Plc (LON:HIK)
Current Year EPS Consensus Estimate: $1.04 EPS


Dividend History for Hikma Pharmaceuticals Plc (LON:HIK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/11/2015GBX 0.210.64%4/16/20154/16/20155/21/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Hikma Pharmaceuticals Plc (LON:HIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/19/2016Ali Al-HusryInsiderBuy50,000GBX 1,790£895,000
12/16/2016Mazen DarwazahInsiderBuy90,730GBX 1,849£1,677,597.70
12/12/2016Ali Al-HusryInsiderBuy50,000GBX 1,707£853,500
12/9/2016Ali Al-HusryInsiderBuy50,000GBX 1,723£861,500
12/6/2016Ali Al-HusryInsiderBuy100,000GBX 1,682£1,682,000
12/5/2016Ali Al-HusryInsiderBuy50,000GBX 1,674£837,000
12/2/2016Mazen DarwazahInsiderBuy50,000GBX 1,662£831,000
12/1/2016Mazen DarwazahInsiderBuy50,000GBX 1,674£837,000
11/30/2016Said DarwazahInsiderBuy50,000GBX 1,662£831,000
9/28/2016Said DarwazahInsiderBuy10,000GBX 2,085£208,500
9/27/2016Ali Al-HusryInsiderBuy50,000GBX 2,094£1,047,000
9/26/2016Said DarwazahInsiderBuy50,000GBX 2,078£1,039,000
9/23/2016Ali Al-HusryInsiderBuy50,000GBX 2,099£1,049,500
9/21/2016Ali Al-HusryInsiderBuy50,000GBX 2,138£1,069,000
9/16/2016Al-Husry,AliInsiderBuy50,000GBX 2,119£1,059,500
9/15/2016Darwazah,SaidInsiderBuy70,251GBX 2,122£1,490,726.22
9/8/2016Darwazah,MazenInsiderBuy150,000GBX 2,162£3,243,000
9/6/2016Darwazah,MazenInsiderBuy155,991GBX 2,194£3,422,442.54
8/31/2016Al-Husry,AliInsiderBuy140,000GBX 2,150£3,010,000
8/26/2016Darwazah,SaidInsiderBuy200,000GBX 2,160£4,320,000
6/24/2016Darwazah,MazenInsiderBuy150,000GBX 2,200£3,300,000
6/17/2016Al-Husry,AliInsiderBuy70,000GBX 22£15,400
5/9/2016Darwazah,SaidInsiderBuy17,440GBX 2,228£388,563.20
4/26/2016Darwazah,SaidInsiderBuy10,000GBX 2,260£226,000
4/25/2016Darwazah,SaidInsiderBuy10,000GBX 2,324£232,400
4/22/2016Darwazah,SaidInsiderBuy30,000GBX 2,325£697,500
4/20/2016Darwazah,SaidInsiderBuy30,000GBX 2,271£681,300
4/19/2016Darwazah,SaidInsiderBuy30,000GBX 2,266£679,800
4/11/2016J. Castellani,JohnInsiderBuy2,500GBX 2,103£52,575
4/7/2016Darwazah,MazenInsiderBuy60,000GBX 2,118£1,270,800
4/5/2016Darwazah,SaidInsiderBuy30,000GBX 2,055£616,500
3/31/2016Darwazah,SaidInsiderBuy30,000GBX 1,972£591,600
3/24/2016Butler,PatInsiderBuy2,500GBX 1,920£48,000
3/21/2016Pickering ,RobertInsiderBuy2,500GBX 1,856£46,400
8/27/2015Kirby,PamelaInsiderBuy3,317GBX 2,264£75,096.88
(Data available from 1/1/2013 forward)


Latest Headlines for Hikma Pharmaceuticals Plc (LON:HIK)
News IconWill AstraZeneca plc Outperform GlaxoSmithKline plc, Shire PLC, Smith & Nephew plc And Hikma Pharmaceuticals Plc After Today’s News? (LON:HIK)
investomania.co.uk - February 17 at 8:39 AM
News IconDelving into The Charts on Hikma Pharmaceuticals PLC (LSE:HIK) - Midway Monitor (LON:HIK)
midwaymonitor.com - February 16 at 5:36 PM
News IconWhat To Expect From Hikma Pharmaceuticals PLC's (LSE:HIK) Earnings In The Year Ahead? - Simply Wall St (LON:HIK)
simplywall.st - February 16 at 5:36 PM
News IconTrading Radar: Zooming in on Shares of Hikma Pharmaceuticals PLC (HIK.L) - Providence Standard (LON:HIK)
providencestandard.com - February 14 at 11:59 PM
News IconStock Levels in Review for Hikma Pharmaceuticals PLC (HIK.L) - Rives Journal (LON:HIK)
rivesjournal.com - February 13 at 11:39 PM
4-traders.com logoTOP NEWS: Hikma Strikes Deal With Finland's Orion For Easyhaler (LON:HIK)
www.4-traders.com - February 13 at 11:30 AM
trustnet.com logoLicensing agreement with Orion for Easyhaler (LON:HIK)
www.trustnet.com - February 13 at 11:30 AM
reuters.com logoBRIEF-Hikma signs licensing deal with Orion for asthma product (LON:HIK)
www.reuters.com - February 13 at 11:30 AM
News IconHikma Pharmaceuticals Agrees Licensing Pact with Orion for Easyhaler (LON:HIK)
ih.advfn.com - February 13 at 11:30 AM
News IconOh, Mother Darling: Grey Gardens Is On the Market (LON:HIK)
ibusinesslines.com - February 10 at 4:37 AM
News IconOprah to Star in Terms of Endearment Remake from Lee Daniels (LON:HIK)
ibusinesslines.com - February 9 at 11:35 PM
News IconGlaxoSmithKline reveals earnings boost from Brexit-hit pound (LON:HIK)
techknowbits.com - February 8 at 11:21 PM
finance.yahoo.com logoPropeller Health Enters into Collaboration to Connect Breezhaler™ Devices to the Propeller Platform (LON:HIK)
finance.yahoo.com - February 8 at 6:20 PM
uk.finance.yahoo.com logoWeak pound buoys GSK but drugmaker warns on 2017 generic threat (LON:HIK)
uk.finance.yahoo.com - February 8 at 6:20 PM
uk.finance.yahoo.com logoA dividend stock and a growth stock I’d buy in February (LON:HIK)
uk.finance.yahoo.com - February 8 at 5:02 AM
directorstalkinterviews.com logoMarket Risers: European Metals Holdings Ltd, Fresnillo Plc ... - DirectorsTalk Interviews (LON:HIK)
www.directorstalkinterviews.com - February 7 at 6:58 PM
News IconTraders are Following Technical Levels for Hikma Pharmaceuticals PLC (HIK.L) - Sherwood Daily (LON:HIK)
sherwooddaily.com - February 6 at 5:44 PM
marketwatch.com logoFTSE 100 moves higher as bank shares rise on Dodd-Frank hopes (LON:HIK)
www.marketwatch.com - February 3 at 4:23 AM
bizjournals.com logoWest-Ward Columbus expects to add 95 jobs in expansion at west Columbus plant, Obetz facility (LON:HIK)
www.bizjournals.com - January 30 at 6:24 PM
News IconWatching ADX Levels for Hikma Pharmaceuticals PLC (HIK.L) - Springdale Times (LON:HIK)
springdaletimes.com - January 26 at 5:06 AM
reuters.com logoTakeda, Hikma clash again in D.C. Circuit over gout drug (LON:HIK)
www.reuters.com - January 26 at 12:05 AM
News IconBroker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC (LON:HIK)
www.youinvest.co.uk - January 25 at 7:04 PM
4-traders.com logoHikma Pharmaceuticals : British stocks gain on Wednesday (LON:HIK)
www.4-traders.com - January 23 at 4:07 PM
News IconRSI, CCI, and ADX Levels in View for Hikma Pharmaceuticals PLC (HIK.L) - Springdale Times (LON:HIK)
springdaletimes.com - January 23 at 11:06 AM
News IconLooking at the Technicals for Hikma Pharmaceuticals PLC (HIK.L) - Springdale Times (LON:HIK)
springdaletimes.com - January 20 at 5:31 AM
News IconHikma Receives FDA Approval for Sodium Oxybate Generic for Narcolepsy with Cataplexy (LON:HIK)
www.sleepreviewmag.com - January 20 at 12:28 AM
4-traders.com logoHikma Pharmaceuticals : receives approval for Sodium Oxybate Oral Solution (LON:HIK)
www.4-traders.com - January 20 at 12:28 AM
4-traders.com logoHikma Pharmaceuticals : Gets US Approval For Generic Cataplexy Drug (LON:HIK)
www.4-traders.com - January 18 at 11:08 PM
nasdaq.com logoHikma's Unit Roxane Gets US Approval For Generic Sodium Oxybate Oral Solution (LON:HIK)
www.nasdaq.com - January 18 at 6:07 PM
marketwatch.com logoHikma unit wins FDA approval for narcolepsy drug (LON:HIK)
www.marketwatch.com - January 18 at 6:07 PM
News IconTechnical Action Update on Shares of Hikma Pharmaceuticals PLC (HIK.L) - Springdale Times (LON:HIK)
springdaletimes.com - January 17 at 11:03 AM
directorstalkinterviews.com logoMarket Risers: Entu (UK) Plc, Fairfx Group PLC, Hikma ... - DirectorsTalk Interviews (LON:HIK)
www.directorstalkinterviews.com - January 17 at 11:03 AM
News IconEUROPE MARKETS: Fiat Rebound Helps Send European Stocks Higher Into The Weekend (LON:HIK)
www.morningstar.com - January 13 at 6:51 PM
News IconCalculating the fair value of Hikma Pharmaceuticals PLC (LSE:HIK) (LON:HIK)
simplywall.st - January 13 at 6:51 PM
marketwatch.com logoFTSE 100 continues record run, rising for 14th day in a row (LON:HIK)
www.marketwatch.com - January 13 at 6:51 PM
News IconHikma Pharmaceuticals PLC Strategy, SWOT and Corporate Finance Report Prices from USD $175 (LON:HIK)
www.bioportfolio.com - January 11 at 6:19 PM
News IconHikma Pharmaceuticals Plc HIK Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (LON:HIK)
www.bioportfolio.com - January 9 at 6:22 PM
trustnet.com logoBroker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC (LON:HIK)
www.trustnet.com - January 5 at 6:40 PM
directorstalkinterviews.com logoHikma Pharmaceuticals Plc 10.4% Potential Upside Indicated by JP Morgan Cazenove - DirectorsTalk Interviews (LON:HIK)
www.directorstalkinterviews.com - January 4 at 3:15 PM
News IconCalculating the intrinsic value of Hikma Pharmaceuticals PLC (LSE:HIK) - Simply Wall St (LON:HIK)
simplywall.st - January 3 at 8:23 PM
4-traders.com logoBritish FTSE 100 edges up slightly Monday (LON:HIK)
www.4-traders.com - December 23 at 5:55 PM
News IconInvestor Circle: Watching the Numbers on Shares of Hikma ... - The Business Journal (LON:HIK)
belmontbusinessjournal.com - December 21 at 11:35 PM
News IconLONDON MARKETS: FTSE 100 Losing Steam After Four Days Of Gains (LON:HIK)
uk.advfn.com - December 21 at 10:26 AM
capitalcube.com logoHikma Pharmaceuticals Plc – Value Analysis (LONDON:HIK) : December 20, 2016 (LON:HIK)
www.capitalcube.com - December 20 at 10:57 AM
capitalcube.com logoHikma Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : HIK-GB : December 19, 2016 (LON:HIK)
www.capitalcube.com - December 19 at 11:39 AM
News IconChecking the Metrics on Shares of Hikma Pharmaceuticals PLC (LSE:HIK) - The Business Journal (LON:HIK)
belmontbusinessjournal.com - December 16 at 4:18 AM
marketwatch.com logoFTSE 100 searches for direction as miners fall, drug makers rise (LON:HIK)
www.marketwatch.com - December 16 at 4:18 AM
News IconF-Score Review on Shares of Hikma Pharmaceuticals PLC (LSE:HIK) - The Business Journal (LON:HIK)
belmontbusinessjournal.com - December 15 at 11:17 PM
reuters.com logoJudge revives Takeda patent lawsuit over Hikma's gout drug (LON:HIK)
www.reuters.com - December 15 at 6:16 PM
law360.com logoTakeda IP Suit Over Hikma Gout Flare Drug Is Reopened (LON:HIK)
www.law360.com - December 15 at 6:16 PM


What is Hikma Pharmaceuticals Plc's stock symbol?

Hikma Pharmaceuticals Plc trades on the London Stock Exchange (LON) under the ticker symbol "HIK."

Where is Hikma Pharmaceuticals Plc's stock going? Where will Hikma Pharmaceuticals Plc's stock price be in 2017?

11 brokers have issued 12-month price targets for Hikma Pharmaceuticals Plc's shares. Their predictions range from GBX 1,800 to GBX 2,900. On average, they expect Hikma Pharmaceuticals Plc's share price to reach GBX 2,300.30 in the next year.

When will Hikma Pharmaceuticals Plc announce their earnings?

Hikma Pharmaceuticals Plc is scheduled to release their next quarterly earnings announcement on Tuesday, March, 14th 2017.

How do I buy Hikma Pharmaceuticals Plc stock?

Shares of Hikma Pharmaceuticals Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Hikma Pharmaceuticals Plc stock cost?

One share of Hikma Pharmaceuticals Plc stock can currently be purchased for approximately GBX 2,034.

Last Updated on 2/19/2017 by MarketBeat.com Staff